Physician profile
Constantine Peter Copses
NPI 1750478772
$355.81
in general payments reported to CMS, 2019-2025
9 companies · $43.37 in 2025
The $43.37 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.18 · 2020: $37.67 · 2021: $71.48 · 2022: $49.97 · 2023: $77.85 · 2024: $47.29 · 2025: $43.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $102.88 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $71.99 | 2021-2022 | |
| Modernatx, INC. | $64.57 | 2023 | Moderna Covid-19 Vaccine |
| Corium, LLC | $29.45 | 2024 | Azstarys |
| Glaxosmithkline, LLC. | $26.72 | 2025 | Bexsero |
| Merck Sharp & Dohme LLC | $17.84 | 2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Collegium Pharmaceutical, INC. | $16.65 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $13.28 | 2023 | Adzenys Xr-Odt |
| Vertical Pharmaceuticals, LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Copses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.